Natalie Torok, MD
Enriched profileProfessor of Medicine (Gastroenterology and Hepatology), Stanford University School of Medicine · Stanford University School of Medicine
Natalie Torok is Professor of Medicine (Gastroenterology and Hepatology), Stanford University School of Medicine at Stanford University School of Medicine. OpenAlex indexes 127 publications with 5,230 citations (h-index 38); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Natalie Torok, M.D., is Professor of Medicine (Gastroenterology and Hepatology), Stanford University School of Medicine. The public record shows 127 publications with 5,230 citations (h-index 38), centered on Liver Disease Diagnosis and Treatment, Liver physiology and pathology, MicroRNA in disease regulation. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 2 companies, 11 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2025 · Nature
- Top research focus: Liver Disease Diagnosis and Treatment
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 58.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Novel MRE Technique to Assess a Risk Factor for Liver Cancer
Sponsor: Natalie Torok
- Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
Sponsor: Stanford University
- The Role of Leptin Receptors in NASH
Sponsor: University of California, Davis
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202417 payments$18,262openpaymentsdata.cms.gov ↗
- Madrigal PharmaceuticalsProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
34.1%Calcineurin inhibitor34.1%Tacrolimus78%Envarsus Xr22%Part D<11 patientsMetabolism & gastrointestinal
21.6%Potassium supplement7.4%Potassium Chloride100%Part D<11 patientsBile Acid7.4%Ursodiol100%Part D<11 patientsAnti-infectives
19.3%Nucleoside and nucleotide reverse transcriptase inhibitors19.3%Tenofovir Disoproxil Fumarate62%Vemlidy38%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
11 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Dysregulated Metabolic-Matrix Axis in MASH/HCC
Palo Alto Veterans Instit for Research
FY2026$633,393R01AG095089 - The Impact of Age on Ketogenesis and the Liver-Gut Axis
Palo Alto Veterans Instit for Research
FY2026$596,400R01AG092825
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease.
The American journal of gastroenterology
Article2025 - Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes.
Hepatology communications
Comment2021 - Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging.
Hepatology (Baltimore, Md.)
Article2020
Most-cited works
by citation count (OpenAlex)- 01
- 02Apoptotic Body Engulfment by a Human Stellate Cell Line Is ProfibrogenicArticle413 citations2003
- 03
- 04
- 05Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liverArticle241 citations2024
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- Bio-X
Stanford University (member)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Mark Pegram, MD
Stanford University School of Medicine
Vibeke Strand, MD
Stanford University School of Medicine